Nicox is a global pharmaceutical company headquartered in Valbonne Sophia Antipolis, France, with subsidiaries in the United States and Italy. The company specializes in the research, development, and commercialization of ophthalmic products, with a particular focus on nitric oxide donation technology.
With expertise in chemistry, manufacturing, and clinical development, Nicox is dedicated to advancing therapeutic solutions for various eye diseases, including glaucoma. Through collaborations with contract research organizations and universities worldwide, the company's research institute in Milan manages an extensive patent portfolio and conducts nonclinical development activities.
Generated from the website
